Morvik Capsule (Meloxicam)

Adult dose

1. Acute exacerbation of osteoarthritis (degenerative arthritis): ○ Adults: Administer 7.5 mg of meloxicam orally once daily. If symptoms do not improve, the dose may be increased to 15 mg per day as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer 15 mg of meloxicam orally once daily. The dose may be reduced to 7.5 mg per day according to the response to treatment. Do not administer more than 15 mg of this drug per day. Take the entire daily dose at once with water or another beverage during a meal. ○ In elderly patients or patients at increased risk of adverse reactions (e.g., those with a history of gastrointestinal disease or cardiovascular risk factors), treatment is usually started at a dose of 7.5 mg per day. ○ Patients with severe renal impairment receiving hemodialysis should not receive more than 7.5 mg per day.

This medication may pose a risk of gastrointestinal bleeding for individuals who consume more than three alcoholic drinks daily; hence, consultation with a physician or pharmacist is mandatory. This medication can affect the cardiovascular system, increasing the risk of serious issues such as heart attack or stroke; therefore, patients with cardiovascular diseases or risk factors should be monitored closely. Because it can cause serious gastrointestinal issues such as bleeding, ulcers, or perforation, particular caution is advised for those with a history of gastrointestinal diseases or the elderly. Rarely, this medication can cause serious allergic reactions or dermatitis; if skin rashes or mucosal damage occur, discontinue use immediately. Kidney function may be affected, so patients with kidney disease or diminished kidney function should use this medication cautiously. If abnormal liver function tests occur, caution is required, and the medication should be discontinued if symptoms worsen. This medication may reduce fertility, so women planning to become pregnant should avoid it. Patients with hypersensitivity or allergies to aspirin or other non-steroidal anti-inflammatory drugs should not take this medication. Patients with active gastric ulcers, bleeding, severe liver impairment, kidney dysfunction, heart failure, hypertension, and certain inflammatory bowel disease should not use this medication. Elderly patients, those with a history of gastrointestinal diseases, patients with weakened kidney or liver function, and those at risk of cardiovascular disease should be monitored closely. This medication can interact with other drugs, especially anticoagulants, lithium, methotrexate, diuretics, and antihypertensives, so consultation with a physician is necessary. During pregnancy, it can be harmful to the fetus; therefore, it should not be used, and breastfeeding women should also avoid taking it. This medication may cause central nervous system symptoms such as drowsiness or dizziness; caution is needed when driving or operating machinery. In case of overdose, symptoms such as nausea, vomiting, and gastrointestinal bleeding may occur, so immediate medical attention is required. This medication should be used at the lowest effective dose for the shortest duration to reduce the risk of side effects, and routine blood tests and liver/kidney function tests should be performed to check for abnormalities. Keep out of reach of children and store in the original container to maintain drug quality.

• Gastrointestinal bleeding
• cardiovascular thrombotic reactions
• myocardial infarction
• stroke
• gastric or intestinal bleeding
• ulcer
• perforation
• exfoliative dermatitis
• Stevens-Johnson syndrome
• toxic epidermal necrolysis

This medication is sensitive to light and should be stored in a light-protective container. Furthermore, it is safe to keep the medication at a temperature between 1 to 30 degrees Celsius. Such storage will help maintain the drug's efficacy.

Appearance

A hard capsule containing a light yellow powder with a light green upper and lower part.

Package unit

30 capsules/bottle, 300 capsules/bottle